YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)	JOURNAL OF THE AMERICAN HEART ASSOCIATION
2022	Monotherapy versus combination therapy of statin and renin-angiotensin system inhibitor in ST-segment elevation myocardial infarction	CARDIOLOGY JOURNAL
2022	Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD	NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2022	Endoscopic vacuum therapy for the management of upper GI leaks and perforations: a multicenter retrospective study of factors associated with treatment failure (with video)	GASTROINTESTINAL ENDOSCOPY
2022	Managing cardiovascular risk in people living with HIV in Asia - where are we now?	HIV MEDICINE
2022	Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma	CANCERS
2022	First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer	ANNALS OF ONCOLOGY
2022	Effects of intravenous iron therapy on mortality and hospitalization of hemodialysis patients: A prospective cohort study in Korea	CLINICAL NEPHROLOGY
2022	Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer	NPJ BREAST CANCER
2022	Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis	DIAGNOSTICS
2022	Selection of X-ray versus magnetic resonance imaging as a first-line imaging modality for diagnosing axial spondyloarthritis	THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
2022	Awakening in extracorporeal membrane oxygenation as a bridge to lung transplantation	ACUTE AND CRITICAL CARE
2022	Serum vitamin D level correlates with disease activity and health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis	ZEITSCHRIFT FUR RHEUMATOLOGIE
2022	Association between dairy protein and body composition in middle-aged and older women: A community-based, 12-year, prospective cohort study	CLINICAL NUTRITION
2022	Clinical Outcomes in Patients With Delayed Hospitalization for Non-ST-Segment Elevation Myocardial Infarction	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2022	Simultaneous Side-by-Side Bilateral Placement of Braided-Type Metal Stents Using a 5.9F Delivery System for Unresectable Malignant Hilar Biliary Obstruction: A Preliminary Feasibility Study	JOURNAL OF INVESTIGATIVE SURGERY
2022	Clinical application of low erythrocyte sedimentation rate/high C-reactive protein to antineutrophil cytoplasmic antibody-associated vasculitis	JOURNAL OF CLINICAL LABORATORY ANALYSIS
2022	External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study	CANCERS
2022	Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients	JOURNAL OF CLINICAL ONCOLOGY
2022	Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma	JOURNAL OF CLINICAL ONCOLOGY